Law and legal

United States Did Tender

📄 Tender ID: 507854237 📅 Published: 02 Sep 2024

📋 Tender Overview

In Law360, White & Case Antitrust partner Kevin Adam provides insight into whether the Medicare drug price negotiation process, under the Inflation Reduction Act, is a true "negotiation" and what, if anything, can be learned from the first round of "negotiations" announced on August 15, 2024.

"Here on the pharma side, given the incentives and the fines and across-the-board impact on all drugs not being able to be covered by Medicare, it really becomes a take-it-or-leave-it scenario for the pharma companies," said Adam.

He added that given that the government only announced the discounts relative to the list prices of drugs, it "makes it really difficult to know how significant some of these discounts actually were, because the list price reductions are less meaningful when looking at a group of drugs that are already highly rebated."

🔍 Key Information

📄
Tender Reference No.
507854237
📅
Publication Date
02 Sep 2024
🌐
Sector
Law and legal
📝
Notice Type
News
📍
Location
United states

📁 Documents & Downloads

No documents found

🏷️ CPV

No CPV found

Need help with this bid?

Our bid experts can help you find, evaluate & win more tenders.

🎧 Talk to Bid Expert
🕒 Submission deadline
0
days remaining · 02 Sep 2024
🔔 Set Alert

🧭 Quick Facts

Authority N/A
Country United states
State / UT N/A
Tender Type Procurement News
Currency N/A
Similar Tenders
Loading similar tenders…